271 related articles for article (PubMed ID: 33012454)
41. Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer.
Keane FK; Hong TS
Cancer Control; 2017; 24(3):1073274817729242. PubMed ID: 28975835
[TBL] [Abstract][Full Text] [Related]
42. High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT.
Hou JZ; Zeng ZC; Wang BL; Yang P; Zhang JY; Mo HF
Jpn J Clin Oncol; 2016 Apr; 46(4):357-62. PubMed ID: 26802166
[TBL] [Abstract][Full Text] [Related]
43. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
McPartlin AJ; Dawson LA
Cancer J; 2016; 22(4):296-301. PubMed ID: 27441750
[TBL] [Abstract][Full Text] [Related]
44. Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma.
Lee IJ; Seong J; Koom WS; Kim YB; Jeon BC; Kim JH; Han KH
Jpn J Clin Oncol; 2011 Jul; 41(7):882-9. PubMed ID: 21515609
[TBL] [Abstract][Full Text] [Related]
45. Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities.
Meyer J; Singal AG
Liver Transpl; 2018 Mar; 24(3):420-427. PubMed ID: 29205797
[TBL] [Abstract][Full Text] [Related]
46. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
Kim JW; Seong J; Lee IJ; Woo JY; Han KH
Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593
[TBL] [Abstract][Full Text] [Related]
47. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.
Zeng ZC; Fan J; Tang ZY; Zhou J; Qin LX; Wang JH; Sun HC; Wang BL; Zhang JY; Jiang GL; Wang YQ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):432-43. PubMed ID: 15667964
[TBL] [Abstract][Full Text] [Related]
48. Advances in Radiotherapy for Prostate Cancer Treatment.
Podder TK; Fredman ET; Ellis RJ
Adv Exp Med Biol; 2018; 1096():31-47. PubMed ID: 30324346
[TBL] [Abstract][Full Text] [Related]
49. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB; Grills IS; Kestin LL; Robertson JM
Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
[TBL] [Abstract][Full Text] [Related]
50. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
[TBL] [Abstract][Full Text] [Related]
51. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.
Schaub SK; Hartvigson PE; Lock MI; Høyer M; Brunner TB; Cardenes HR; Dawson LA; Kim EY; Mayr NA; Lo SS; Apisarnthanarax S
Technol Cancer Res Treat; 2018 Jan; 17():1533033818790217. PubMed ID: 30068240
[TBL] [Abstract][Full Text] [Related]
52. Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases.
Chen YX; Zeng ZC; Fan J; Tang ZY; Zhou J; Zeng MS; Zhang JY; Sun J
Clin Transl Oncol; 2013 Sep; 15(9):732-40. PubMed ID: 23381897
[TBL] [Abstract][Full Text] [Related]
53. Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma.
Han B; Shao L; Li C; Xu Y; Tang Y; Han L; Qi X
J BUON; 2019; 24(4):1390-1401. PubMed ID: 31646782
[TBL] [Abstract][Full Text] [Related]
54. Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.
Eccles CL; Bissonnette JP; Craig T; Taremi M; Wu X; Dawson LA
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):582-8. PubMed ID: 18793961
[TBL] [Abstract][Full Text] [Related]
55. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma.
Abe T; Saitoh J; Kobayashi D; Shibuya K; Koyama Y; Shimada H; Shirai K; Ohno T; Nakano T
Radiat Oncol; 2015 Sep; 10():187. PubMed ID: 26377092
[TBL] [Abstract][Full Text] [Related]
56. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis.
Chen MY; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Tsang NM; Chan KM; Lee WC
Biomed Res Int; 2016; 2016():6017406. PubMed ID: 27999803
[No Abstract] [Full Text] [Related]
58. Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion.
McGee HM; King MJ; Özbek U; Olson A; Kim E; Fischman AM; Schwartz M; Rosenzweig KE; Buckstein M
Am J Clin Oncol; 2019 Apr; 42(4):367-374. PubMed ID: 30724782
[TBL] [Abstract][Full Text] [Related]
59. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
[TBL] [Abstract][Full Text] [Related]
60. External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy.
Fuss M; Salter BJ; Herman TS; Thomas CR
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S206-17. PubMed ID: 15508086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
